Optimization and prevalidation of the in vitro ER alpha CALUX method to test estrogenic and antiestrogenic activity of compounds

B. van der Burg, R. Winter, M. Weimer, P. Berckmans, G. Suzuki, L. Gijsbers, A. Jonas, S. van der Linden, H. Witters, J.M.M.J.G. Aarts, J. Legler, A. Kopp-Schneider, S. Bremer

Research output: Contribution to journalArticleAcademicpeer-review

54 Citations (Scopus)

Abstract

Estrogenicity of chemicals has received significant attention and is linked to endocrine-disrupting activities. However, there is a paucity of validated methods to assess estrogenicity in vitro. We have established a robust method to test estrogenic and antiestrogenic activity of compounds in vitro, as an alternative to using animal models such as the uterotrophic assay. To this end we optimized protocols to be used in combination with CALUX reporter gene assays and carried out an in house prevalidation, followed by two rounds of tests to establish transferability. Problems in the initial test with transferability were solved by isolation of a novel cell clone of the ER alpha CALUX line with greatly improved stability and luciferase levels. This cell line proved to be a very suitable and reliable predictor of estrogenicity of chemicals and was able to readily rank a range of chemicals on the basis of their EC50 values.
Original languageEnglish
Pages (from-to)73-80
JournalReproductive Toxicology
Volume30
Issue number1
DOIs
Publication statusPublished - 2010

Keywords

  • cell-line
  • transactivation assay
  • endocrine disruptors
  • bioassays
  • androgen
  • chemicals
  • panel
  • beta

Fingerprint Dive into the research topics of 'Optimization and prevalidation of the in vitro ER alpha CALUX method to test estrogenic and antiestrogenic activity of compounds'. Together they form a unique fingerprint.

Cite this